Hollywood Mark

EVP & Chief Operating Officer

Hollywood Mark has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jul 6, 2026.

On the most recent filing, Hollywood Mark is listed as EVP & Chief Operating Officer at Zymeworks Inc. Inside the rolling window, Hollywood Mark reported no open-market purchases and 1 open-market sale totaling $139K in ZYME.

Companies traded

Other insiders at ZYME

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$139K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ZYMESale$139KJan 13SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Hollywood Mark made?

Hollywood Mark has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.

Which companies does Hollywood Mark trade?

Hollywood Mark has filed SEC Form 4 disclosures for 1 company, including ZYME.

When was Hollywood Mark's most recent SEC Form 4 filing?

Hollywood Mark's most recent SEC Form 4 filing on Tracefour is dated Jul 6, 2026.

What is Hollywood Mark's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Hollywood Mark is listed as EVP & Chief Operating Officer.

What is Hollywood Mark's total buy and sell value in the current window?

Inside the rolling retention window, Hollywood Mark bought $0 and sold $139K based on SEC Form 4 filings.

What was Hollywood Mark's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 6,120 ZYME shares on 2026-01-12, worth $139K, per SEC Form 4 filings.